This inventor holds 2 USPTO granted patents. Top assignee: Jiangsu Alphamab Biopharmaceuticals Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Pilin Wang - Innovator in Tumor Treatment
Introduction
Pilin Wang is a notable inventor based in Suzhou, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative treatments for tumors. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Pilin Wang holds a patent for a bispecific fusion protein designed for tumor treatment. This innovative approach aims to enhance the efficacy of cancer therapies, providing new hope for patients battling this challenging disease. His patent portfolio includes 1 patent that reflects his dedication to research and development in the biopharmaceutical sector.
Career Highlights
Wang is currently employed at Jiangsu Alphamab Biopharmaceuticals Co., Ltd., where he continues to push the boundaries of cancer treatment. His role at the company allows him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development initiatives.
Collaborations
Pilin Wang has worked alongside esteemed colleagues such as Kangping Guo and Yuhao Jin. These collaborations have fostered a dynamic environment for innovation and have played a crucial role in the advancement of their shared goals in biopharmaceutical research.
Conclusion
Pilin Wang's contributions to tumor treatment through his innovative patent and collaborative efforts highlight his importance in the biopharmaceutical industry. His work continues to inspire advancements in cancer therapies, making a significant impact on the lives of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile